Comparative efficacy and safety of teriparatide versus bisphosphonates in osteoporosis: a meta-analysis
Teriparatide demonstrated superior efficacy in reducing vertebral/non-vertebral fracture risks and improving BMD in both short- and long-term treatments, with a safety profile comparable to bisphosphonates.
Authors
- Bo Shuai (ORCID: https://orcid.org/0000-0002-9298-8129)
- Zixian Wang (ORCID: https://orcid.org/0000-0002-7950-787X)
- Song Shi (ORCID: https://orcid.org/0009-0001-1533-5415)
- Cai Huang
- Lin Shen (ORCID: https://orcid.org/0000-0002-8798-4756)
- Di Wang (ORCID: https://orcid.org/0000-0003-2059-7054)
- Man Chen (ORCID: https://orcid.org/0009-0006-4599-7328)
- Ying Dong (ORCID: https://orcid.org/0000-0003-4652-3221)
- Ziyi He
- Xin Jin (ORCID: https://orcid.org/0009-0008-4537-3544)
Institutions
- Dongfeng Motor Group (China) (CN)
- Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Wuhan Sports University (CN)
Publication Details
- Journal
- Frontiers in Surgery
- Published
- 2025-12-08
- DOI
- https://doi.org/10.3389/fsurg.2025.1582180
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00